SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-14-000445
Filing Date
2014-02-04
Accepted
2014-02-04 07:01:01
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT dara_10k.htm 10-K 1769280
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dara_ex231.htm EX-23.1 2981
3 CERTIFICATION dara_ex311.htm EX-31.1 10000
4 CERTIFICATION dara_ex312.htm EX-31.2 10146
5 CERTIFICATION dara_ex321.htm EX-32.1 6370
  Complete submission text file 0001354488-14-000445.txt   6038855

Data Files

Seq Description Document Type Size
6 dara-20131231.xml EX-101.INS 667138
7 dara-20131231.xsd EX-101.SCH 50440
8 dara-20131231_cal.xml EX-101.CAL 54567
9 dara-20131231_def.xml EX-101.DEF 104867
10 dara-20131231_lab.xml EX-101.LAB 369165
11 dara-20131231_pre.xml EX-101.PRE 256675
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 (816) 914-7027
DARA BioSciences, Inc. (Filer) CIK: 0000919745 (see all company filings)

IRS No.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23776 | Film No.: 14570032
SIC: 2834 Pharmaceutical Preparations